BioTelemetry, Inc. Earnings Conference Call (Q4 2013) Today's Calls 
Visit the TF Network Sites
Visit the TF Network Sites
· Corporate IR Center
· Institutional Investor Center
· Individual Investor Center
Download Plug-In
Real Player 8 Basic
Windows Media Player
Other Conference Calls
Other Mar 5 Calls
Today's Calls
Call Details
BioTelemetry, Inc. Earnings Conference Call (Q4 2013)
Scheduled to start Wed, Mar 5, 2014, 3:30 am Eastern

-- this event is ongoing now--
Listen to the ongoing live event audio stream

About Scor SE (Paris:SCR.PA)
SCOR SE provides life and non-life reinsurance products. The company’s SCOR Global P&C segment offers non-life reinsurance products in the areas of property and casualty treaties; specialty lines, including credit and surety, inherent defects insurance, aviation, space, marine, engineering, agriculture, and structured risk transfer; business solutions; and joint ventures and partnerships. Its SCOR Global Life segment offers life reinsurance products that cover life mortality, life financing, short-term and long-term disability, long term care, critical illness/dread disease, health, annuities, personal accident, longevity, and preferred lives. The company also underwrites direct insurance primarily on a business-to-business basis to cover certain non-life large industrial risks. In addition, it is involved in the asset management business. SCOR SE was founded in 1970 and is headquartered in Paris, France.

More Info: Quote | News | Profile

Copyright © 2014 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Copyright © 2014 FirstCall Events. Historical chart data provided by Commodity Systems, Inc. (CSI). Company profile information presented on this page is Copyright Capital IQ. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.